http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Diplomat Celebrates National Pharmacy Week in Honor of Patients & Caregivers
-
Diplomat to Distribute COAGADEX® for the Treatment of Hereditary Factor X Deficiency
-
Notable Analyst Rating Changes 10/21: (COH) (WM) (EXAS) Upgraded; (TWTR) (MU) (IAG) Downgraded
-
Diplomat to Release Third Quarter Operating Results and Host Conference Call on Tuesday, November 3, 2015
-
Diplomat Recognized as One of Michigan's Best and Brightest in Wellness
-
Notable Analyst Rating Changes 10/14: (ADI) (DPLO) (INTC) Upgraded; (GPRO) (TWTR) (SB) Downgraded
-
Pre-Open Stock Movers 10/14: (TRIP) (CASI) (SNDK) Higher; (CPHD) (CFX) (DOC) Lower (more...)
-
Diplomat to Dispense Taiho Drug, LONSURF® (trifluridine and tipiracil)
-
Shawn Cline Tomasello and Benjamin Wolin appointed to Diplomat Board of Directors
-
Diplomat Addresses Unusual Market Activity
-
Diplomat to Dispense Cholesterol-Lowering Drug, REPATHA™
-
Diplomat to Participate in Upcoming Investor Conferences
-
Diplomat Celebrates 2nd Successful Summer with its Internship and Fellowship Programs
-
Diplomat's Marketing and Public Relations Team Receives 10 Awards from Graphic Design USA
-
Diplomat to Exclusively Dispense Taro Drug KEVEYIS™
-
Diplomat to Dispense AstraZeneca Drug IRESSA®
-
Diplomat Announces 2nd Quarter 2015 Financial Results
-
Diplomat to Dispense DAKLINZA® for Hepatitis C Treatment
-
Diplomat Partners with Pharmaca to Offer Specialty Medications
-
BioRx Named a Top Workplace in 2015 by Enquirer Media
-
American Homecare Federation Receives Top Satisfaction Rating
-
Burman's Specialty Pharmacy study shows hepatitis C cure possible while cutting a third of the drug costs
-
Diplomat expands hepatitis C specialty services with acquisition of Burman's Specialty Pharmacy
-
Diplomat Named a Preferred Specialty Pharmacy Vendor by the Association for Community Affiliated Plans (ACAP)
-
Diplomat to Participate in Upcoming Investor Conferences
-
Diplomat Releases 2014 Satisfaction Survey Results
-
Diplomat Announces 1st Quarter Financial Results
-
GE Capital Provides $320 Million Credit Facility to Diplomat Pharmacy, Includes Funds for Acquisition of BioRx
-
Diplomat to Release First Quarter Operating Results and Host Conference Call on Monday, May 11, 2015
-
Diplomat Launches National Search for Internship and Fellowship in Flint
-
Diplomat Names Shannon M. Beltrand as New CISO
-
Diplomat to Dispense Novartis Drug, JADENU™
-
Diplomat Celebrates 40th Anniversary
-
Diplomat Completes Acquisition of BioRx
-
Diplomat Selected to Dispense KITABIS™ PAK for Cystic Fibrosis

